Genetic markers in lung cancer diagnosis: a review

K Wadowska, I Bil-Lula, Ł Trembecki… - International journal of …, 2020 - mdpi.com
Lung cancer is the most often diagnosed cancer in the world and the most frequent cause of
cancer death. The prognosis for lung cancer is relatively poor and 75% of patients are …

Evolution and progression of Barrett's oesophagus to oesophageal cancer

S Killcoyne, RC Fitzgerald - Nature Reviews Cancer, 2021 - nature.com
Cancer cells are shaped through an evolutionary process of DNA mutation, cell selection
and population expansion. Early steps in this process are driven by a set of mutated driver …

Insights into lung cancer immune-based biology, prevention, and treatment

S Saab, H Zalzale, Z Rahal, Y Khalifeh… - Frontiers in …, 2020 - frontiersin.org
Lung cancer is the number one cause of cancer-related deaths. The malignancy is
characterized by dismal prognosis and poor clinical outcome mostly due to advanced-stage …

Smoking and lung cancer: a geo-regional perspective

Z Rahal, S El Nemr, A Sinjab, H Chami, A Tfayli… - Frontiers in …, 2017 - frontiersin.org
Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung
cancer (NSCLC) represents the most frequently diagnosed subtype of this morbid …

Genome evolution in ductal carcinoma in situ: invasion of the clones

AK Casasent, M Edgerton… - The Journal of pathology, 2017 - Wiley Online Library
Ductal carcinoma in situ (DCIS) is the most frequently diagnosed early‐stage breast cancer.
Only a subset of patients progress to invasive ductal carcinoma (IDC), and this presents a …

Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response

SE Willis, C Winkler, MP Roudier, T Baird… - British Journal of …, 2021 - nature.com
Background The absence of the putative DNA/RNA helicase Schlafen11 (SLFN11) is
thought to cause resistance to DNA-damaging agents (DDAs) and PARP inhibitors. Methods …

Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer

CG Kim, G Kim, KH Kim, S Park, S Shin… - Journal for …, 2021 - pmc.ncbi.nlm.nih.gov
Background Reinvigoration of T-cell exhaustion with antibodies has shown promising
efficacy in patients with non-small-cell lung cancer (NSCLC). However, the characteristics of …

Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer

YA Jakubek, K Chang, S Sivakumar, Y Yu… - Nature …, 2020 - nature.com
Mosaicism, the presence of subpopulations of cells bearing somatic mutations, is associated
with disease and aging and has been detected in diverse tissues, including apparently …

Rationale for lung adenocarcinoma prevention and drug development based on molecular biology during carcinogenesis

H Zhang, L Guo, J Chen - OncoTargets and therapy, 2020 - Taylor & Francis
Lung adenocarcinoma (LUAD) is the most common and aggressive subtype of lung cancer
with the greatest heterogeneity and aggression. Inspite of recent years' achievements in …

Game of clones: Battles in the field of carcinogenesis

Z Rahal, A Sinjab, II Wistuba, H Kadara - Pharmacology & therapeutics, 2022 - Elsevier
Recent advances in bulk sequencing approaches as well as genomic decoding at the single-
cell level have revealed surprisingly high somatic mutational burdens in normal tissues, as …